徐国辰，男，博士，心血管专业，副主任医师。 1983~1989第四军医大学医疗系本科，获学士学位；1991~1994第四军医大学研究生院心血管病学专业，获硕士学位；2003~2005第四军医大学药学系药理学专业/北京大学人民医院心血管病研究所，获博士学位。 师从张宁仔、杜日映教授攻读硕士学位期间，从事全军“八五”攻关课题“血管支架预防/治疗PTA/PTCA术后急性闭塞与慢性再狭窄”研究，研制成功首例国产不锈钢动脉血管支架。 师从梅其柄、胡大一教授攻读博士学位期间，从事“药物基因组学与脂代谢紊乱患者的个体化治疗”研究，开始涉足药物相互作用和药物个体化治疗与遗传基因多态性的相关研究领域。 自2000年从事心血管专科门诊工作以来，开展心血管疾病的循证医学研究，发表相关研究论文20余篇，参编心血管病学专著2部。2000年获、中医药管理局、解放军总后勤部联合举办的“中医药科技大会”论文奖；2004年赴新加坡参加“亚洲青年心血管病医生论坛”国际会议，就在本土开展的“药物基因组学与脂代谢紊乱患者的个体化治疗研究”发表演讲。 Dr. Xu Guochen, associate chief physician, specializes in cardiovascular diseases. Dr. Xu graduated from the department of medicine (six-year course) of the Fourth Military Medical University in 1989, and was awarded Medical Bachelor Degree. He majored cardiovascular diseases at graduate school of the Fourth Military Medical University from 1991 to 1994, and was awarded Master Degree of Medical Science. He majored in cardiovascular pharmacology at the department of pharmacology of the Fourth Military Medical University and Angiocardiopathy Institute of Peking University People's Hospital from 2002 to 2005, and was awarded Doctoral Degree of Medical Science. Dr. Xu studied for master degree under supervision of professors Zhang Ningzi and Du Riying, and his research was focused on Preventing/Curing PTA/PTCA Postoperative Acute Closure and Chronic Restenosis by using Stent for Key Technologies Research and Development Program of the army during the 8th Five-Year Plan Period. He successfully developed the first domestic stainless steel coronary stent in China. Dr. Xu’s doctoral study on pharmacogenomics of individualized treatment of lipid metabolism disorder was conducted under supervision of professors Mei Qibing and Hu Dayi. Meanwhile Dr. Xu initiated the investigation on drug interactions, clinical individualized treatment genetic polymorphism. Dr. Xu has been working on evidence-based cardiovascular medicine since 2000. He has published more than 20 research articles, and participated in compiling of two cardiovasculogical monographs, and won the Prize for the Excellent Papers in China Technology Conference on TCM co-sponsored by Ministry of Public Health, State Administration of Traditional Chinese Medicine and The General Logistics Department of PLA in 2000. He presented orally his study on pharmacogenomics of individualized treatment of lipid metabolism disorder at the International Conference of Asian Youth Specialist Forum on Angiocardiopathy in Singapore in 2004.